Early anticoagulant treatment shown to reduce death in moderately ill COVID-19 patients
COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death. New trial results show that administering ...